Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Neurology
Parkinson's Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Phase II - Assessing the efficacy and safety of a new investigational drug when used together with a stable dose of L-dopa in the treatment of Parkinson's Disease
Phase II - Determining Mirapex ER efficacy, safety and tolerability in the treatment Parkinson's Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
Have you been recently diagnosed with Parkinson's Disease?
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Parkinson's Disease - Adults
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Parkinson Disease: Announcing a Research Study for Patients with Parkinson’s Disease
Parkinson Disease: Neuroimaging Research Study on Depression in Parkinson's Disease
Parkinson Disease: Volunteers Needed for Parkinson’s Disease Research Study
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Psychosocial Treatment of Depression in Parkinson's Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Parkinson's Disease Treatment for new onset PD
Research study of investigational medication for people with new-onset Parkinson's Disease while taking a Dopamine Agonist (e.g. Requip)
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Parkinson's Disease - Adults
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Parkinson Disease Collaborative Study of Genetic Linkage
Parkinson's Disease - Adults
Parkinson's Disease - Deep Brain Stimulation
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
24-Hour Treatment for Parkinson's Patient
Gene Transfer Study for People with Advanced Parkinson’s Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
Parkinson’s Research
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Gene Transfer Study for People with Advanced Parkinson’s Disease
UVa Health System, Department of Neurology, seeks Woman and Men with Parkinsons Disease for research study.
Gene Transfer Study for People with Advanced Parkinson’s Disease
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Study to Evaluate Efficacy of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension